Skip to main content
AI Market Watch
Loading...

Ovum

Category: AI in Healthcare

An AI-powered intelligent health journal and mobile app designed to empower women to track symptoms, gain personalized health insights, and advocate for better healthcare outcomes. Ovum was founded in 2023. The company is led by Dr Ariella Heffernan-Marks. Based in Sydney, Australia. Team size: 2-10. Total funding raised: $5.7 million. Latest round: Seed, $1.7M, 2025-02, led by Giant Leap. Key investors include Giant Leap, Antler, Alice Anderson Fund, Wollemi Capital Group, Admiralty Capital Group, Foggy Valley Aotearoa, Aviron Investments, Brisbane Angels, Think & Grow.

Founded
2023
Headquarters
Sydney, Australia
Team size
2-10
Total funding
$5.7 million

Value proposition

To provide women with a non-judgmental, AI-powered tool to track their health, receive personalized insights, and generate comprehensive health reports to facilitate more effective communication with doctors, ultimately addressing the gender gap in healthcare.

Products and solutions

An intelligent health journal mobile app that integrates and stores medical information such as blood tests, imaging reports, and referrals., Interactive features for health and cycle tracking., An AI-powered assistant to answer health questions and provide personalized insights.

Unique value

Ovum is Australia's first holistic AI health assistant for women, offering a non-judgmental space for users to ask questions and track their health, aiming to combat medical gaslighting and the dismissal of women's health concerns.

Target customer

Women seeking to better understand and manage their health, particularly those with chronic conditions like endometriosis, who feel their health concerns have been dismissed by the medical system.

Industries served

Healthcare, Femtech, Artificial Intelligence

Technology advantage

The core technological advantage is the development of a proprietary women-specific AI dataset, addressing the lack of diverse data in women's health to provide more accurate and personalized insights. The platform is being co-designed with user feedback and clinical trials.

How they differentiate

Ovum differentiates itself by creating a unique, longitudinal dataset specifically for women's health in Australia to address historical data gaps. It focuses on complex and underserved conditions like endometriosis and PCOS, positioning itself as a clinical-grade tool that integrates various medical records, including blood tests and imaging reports, rather than just being a symptom tracker.

Main competitors

Flo Health, Clue, Qoala

Key partnerships

Co-created with venture partner Nakatomi, Received funding from Giant Leap, Antler, Alice Anderson Fund, and Wollemi Capital Group

Notable customers

Ovum is conducting clinical trials in partnership with UNSW (University of New South Wales), The George Institute for Global Health, The Royal Hospital for Women, and St George Hospital., Over 113,000 conversations logged since launch with women across Australia and New Zealand.

Major milestones

Secured $1.7 million in a pre-seed funding round (Feb 2025)., Launched its AI-powered women's health platform (Aug 2025)., Commenced clinical trials with two leading women's hospitals., Won the inaugural SXSW Sydney 2023 AI Pitch Competition., Raised $4 million Seed round led by Admiralty Capital Group (June 2026), tripling valuation to ~$18M., Named Best New Founder at Startup Daily Best in Tech Awards 2026., Featured in Forbes Asia 100 to Watch 2026.

Growth metrics

As of mid-2026, Ovum has surpassed the pilot phase: 20,000+ app downloads, 113,000+ AI health conversations logged, growing ~30% month-on-month.

Market positioning

Ovum is positioned as a sophisticated, AI-powered health assistant and intelligent journal, rather than just a period or fertility tracker. It targets both individual consumers and enterprise partners, including employers and healthcare institutions, through pilot programs and clinical trials.

Geographic focus

Australia

Patents and IP

No public information available.

About Dr Ariella Heffernan-Marks

Medical Doctor with a special interest in reproductive biology, Founder of two companies in the healthcare space.

More AI in Healthcare companies

Official website:

Ovum - AI Startup Profile | AI Market Watch